Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial.

Szakacs Z, Dauvilliers Y, Mikhaylov V, Poverennova I, Krylov S, Jankovic S, Sonka K, Lehert P, Lecomte I, Lecomte JM, Schwartz JC, HARMONY-CTP study group

Open source

DOI
10.1016/s1474-4422(16)30333-7
Published
2017 Mar
Container
The Lancet. Neurology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s1474-4422-16-30333-7,
  title = {Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial.},
  author = {Szakacs Z and Dauvilliers Y and Mikhaylov V and Poverennova I and Krylov S and Jankovic S and Sonka K and Lehert P and Lecomte I and Lecomte JM and Schwartz JC and HARMONY-CTP study group},
  year = {2017},
  journal = {The Lancet. Neurology},
  doi = {10.1016/s1474-4422(16)30333-7},
  url = {https://doi.org/10.1016/s1474-4422(16)30333-7}
}

RIS

TY  - JOUR
TI  - Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial.
AU  - Szakacs Z
AU  - Dauvilliers Y
AU  - Mikhaylov V
AU  - Poverennova I
AU  - Krylov S
AU  - Jankovic S
AU  - Sonka K
AU  - Lehert P
AU  - Lecomte I
AU  - Lecomte JM
AU  - Schwartz JC
AU  - HARMONY-CTP study group
PY  - 2017
JO  - The Lancet. Neurology
DO  - 10.1016/s1474-4422(16)30333-7
UR  - https://doi.org/10.1016/s1474-4422(16)30333-7
ER  - 

APA

Z, S., Y, D., V, M., I, P., S, K., S, J., K, S., P, L., I, L., JM, L., JC, S., & group, H. S. (2017). Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial.. The Lancet. Neurology. https://doi.org/10.1016/s1474-4422(16)30333-7

Source records